pyridinolcarbamate has been researched along with Buerger Disease in 2 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mishima, Y | 1 |
| Kamiya, K | 1 |
| Sakaguchi, S | 1 |
| Kusaba, A | 1 |
| Sakuma, A | 1 |
| Zelikovsky, A | 1 |
| Urca, I | 1 |
| Shaklai, M | 1 |
| de Vries, A | 1 |
2 trials available for pyridinolcarbamate and Buerger Disease
| Article | Year |
|---|---|
A multiclinic double-blind trial of pyridinolcarbamate and inositol niacinate in ischemic ulcer due to chronic arterial occlusion.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Arterial Occlusive Diseases; Arteriosclerosis; Aspart | 1977 |
A clinical trial with pyridinolcarbamate in the treatment of patients with obstructive diseases of the peripheral arteries.
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Carbamates; Female; Femoral Artery; Gait; Human | 1973 |